Tom Greene Selected Research

Renal Insufficiency (Renal Failure)

11/2021	Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
1/2021	A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.
1/2021	Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
1/2021	Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease.
12/2020	Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial.
10/2020	The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
1/2020	Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.
1/2019	Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.
1/2019	Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
1/2019	Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tom Greene Research Topics

Disease

70	Chronic Renal Insufficiency 01/2022 - 12/2002
41	Kidney Diseases (Kidney Disease) 12/2020 - 07/2002
34	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 07/2003
26	Renal Insufficiency (Renal Failure) 11/2021 - 07/2003
24	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2008
19	Hypertension (High Blood Pressure) 08/2017 - 07/2002
18	Albuminuria 01/2022 - 01/2003
17	Proteinuria 01/2021 - 01/2005
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2003
12	Heart Failure 01/2022 - 01/2004
11	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 12/2002
9	Fistula 11/2018 - 01/2005
9	Inflammation (Inflammations) 01/2016 - 12/2003
8	Arteriovenous Fistula 11/2018 - 01/2005
7	Atrial Fibrillation 01/2022 - 09/2009
7	Infections 01/2020 - 12/2002
6	Fibrosis (Cirrhosis) 01/2022 - 01/2016
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2003
5	Body Weight (Weight, Body) 01/2021 - 09/2003
5	Pneumonia (Pneumonitis) 01/2020 - 05/2015
5	Thrombosis (Thrombus) 01/2018 - 01/2005
5	Hyperphosphatemia 01/2017 - 12/2010
4	Pain (Aches) 01/2022 - 07/2004
4	Acidosis 08/2017 - 12/2003
4	Nephrosclerosis 11/2010 - 12/2004
3	Low Back Pain (Lumbago) 01/2022 - 01/2017
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2021 - 09/2016
3	Disease Progression 10/2020 - 06/2008
3	Diabetes Mellitus 01/2020 - 01/2018
3	Pathologic Constriction (Stenosis) 10/2017 - 01/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 06/2011
3	Malnutrition (Nutritional Deficiencies) 12/2010 - 07/2003
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2022 - 02/2011
2	Diarrhea 01/2021 - 10/2020
2	Hypotension (Low Blood Pressure) 01/2021 - 04/2008
2	Iron Deficiencies 01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

48	CreatinineIBA 01/2022 - 01/2003
21	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2005
19	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2006
18	AlbuminsIBA 11/2021 - 01/2003
11	CanagliflozinIBA 01/2022 - 12/2017
11	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 07/2002
10	dapagliflozinIBA 01/2022 - 01/2020
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2014
10	C-Reactive ProteinIBA 01/2016 - 12/2002
9	Dietary ProteinsIBA 09/2017 - 04/2005
8	Bicarbonates (Hydrogen Carbonate)IBA 01/2018 - 01/2006
8	Serum AlbuminIBA 10/2014 - 12/2002
7	Urea (Carbamide)FDA LinkGeneric 08/2013 - 09/2003
6	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 09/2006
6	MineralsIBA 09/2015 - 09/2005
6	HomocysteineIBA 12/2012 - 11/2002
5	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2019
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2014 - 07/2003
5	Ramipril (Altace)FDA LinkGeneric 01/2013 - 07/2003
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2019
4	IronIBA 01/2021 - 02/2015
4	Pharmaceutical PreparationsIBA 01/2021 - 07/2005
4	Vancomycin FDA LinkGeneric 01/2020 - 11/2015
4	Cystatin CIBA 01/2019 - 07/2007
4	Phosphorus (Red Phosphorus)IBA 02/2015 - 09/2005
4	Triglycerides (Triacylglycerol)IBA 12/2012 - 01/2005
4	HDL CholesterolIBA 12/2012 - 09/2006
3	Transferrin (beta 2 Transferrin)IBA 01/2021 - 03/2017
3	DiureticsIBA 01/2021 - 09/2009
3	Ferritins (Ferritin)IBA 01/2021 - 03/2017
3	Azithromycin (Zithromax)FDA LinkGeneric 11/2020 - 11/2015
3	SodiumIBA 10/2020 - 11/2006
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2018 - 11/2006
3	Indicators and Reagents (Reagents)IBA 10/2018 - 08/2017
3	AcidsIBA 01/2018 - 03/2015
3	PotassiumIBA 08/2017 - 11/2006
3	Phosphates (Orthophosphate)IBA 01/2017 - 10/2011
3	ferric citrateIBA 01/2017 - 09/2015
3	SteroidsIBA 09/2016 - 10/2015
3	hydroxide ionIBA 01/2016 - 04/2012
3	Uric Acid (Urate)IBA 01/2016 - 05/2009
3	AdiponectinIBA 01/2016 - 09/2006
3	Angiotensin Receptor AntagonistsIBA 10/2014 - 04/2008
3	CholesterolIBA 02/2014 - 09/2010
3	NitrogenIBA 08/2013 - 10/2006
3	LipidsIBA 06/2013 - 01/2005
3	Fibroblast Growth Factor-23IBA 01/2013 - 10/2011
3	25-hydroxyvitamin DIBA 12/2012 - 04/2012
3	Dialysis SolutionsIBA 04/2012 - 09/2003
3	Alkaline PhosphataseIBA 06/2011 - 11/2009
3	Iothalamic Acid (Iotalamic Acid)FDA Link 07/2007 - 12/2004
3	Amlodipine (Norvasc)FDA LinkGeneric 11/2006 - 07/2005
3	Metoprolol (Toprol-XL)FDA LinkGeneric 11/2006 - 07/2005
2	N-methylvalineIBA 01/2022 - 12/2020
2	Angiotensin IIIBA 01/2021 - 02/2014
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 11/2005

Therapy/Procedure

29	Renal Dialysis (Hemodialysis) 01/2019 - 12/2003
26	Therapeutics 01/2021 - 07/2003
4	Physical Therapy Modalities (Physical Therapy Technique) 01/2022 - 01/2017
4	Transplantation 01/2019 - 12/2006
4	Length of Stay 09/2015 - 09/2012
3	Catheter Ablation 01/2022 - 02/2014
3	Protein-Restricted Diet (Diet, Protein Restricted) 02/2009 - 04/2005
3	Catheters 11/2008 - 01/2004